Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03596203 · ClinicalTrials.gov registry record · Phase 1
TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy
A Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03596203 is a Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 17 participants.
The verdict
NCT03596203, a Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The study will evaluate whether an experimental medical device that emits a series of brief, intense magnetic pulse will relieve foot pain from Diabetic Neuropathy (DN). The United States Food and Drug Administration (FDA) has approved a similar device for treatment of migraine headaches, but this type of device has not been studied for the treatment of DN.
Interventions
- DEVICE TransCutaneous Magnetic Stimulator (TCMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2019-07-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03596203
The ClinicalTrials.gov registry entry for NCT03596203 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TransCutaneous Magnetic Stimulator (TCMS) is the first listed.
NCT03596203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03596203 about?
NCT03596203 is a clinical study titled "TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy". The study will evaluate whether an experimental medical device that emits a series of brief, intense magnetic pulse will relieve foot pain from Diabetic Neuropathy (DN). The United States Food and Drug Administration (FDA) has approved a similar device for treatment of migraine headaches, but this t...
What is the current status of trial NCT03596203?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2018-11-01. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03596203?
The interventions under investigation include: TransCutaneous Magnetic Stimulator (TCMS) (DEVICE).
Who is sponsoring clinical trial NCT03596203?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.